Haduch, A.; Bromek, E.; Pukło, R.; Jastrzębska, J.; Danek, P.J.; Daniel, W.A.
The Effect of the Selective N-methyl-D-aspartate (NMDA) Receptor GluN2B Subunit Antagonist CP-101,606 on Cytochrome P450 2D (CYP2D) Expression and Activity in the Rat Liver and Brain. Int. J. Mol. Sci. 2022, 23, 13746.
https://doi.org/10.3390/ijms232213746
AMA Style
Haduch A, Bromek E, Pukło R, Jastrzębska J, Danek PJ, Daniel WA.
The Effect of the Selective N-methyl-D-aspartate (NMDA) Receptor GluN2B Subunit Antagonist CP-101,606 on Cytochrome P450 2D (CYP2D) Expression and Activity in the Rat Liver and Brain. International Journal of Molecular Sciences. 2022; 23(22):13746.
https://doi.org/10.3390/ijms232213746
Chicago/Turabian Style
Haduch, Anna, Ewa Bromek, Renata Pukło, Joanna Jastrzębska, Przemysław Jan Danek, and Władysława Anna Daniel.
2022. "The Effect of the Selective N-methyl-D-aspartate (NMDA) Receptor GluN2B Subunit Antagonist CP-101,606 on Cytochrome P450 2D (CYP2D) Expression and Activity in the Rat Liver and Brain" International Journal of Molecular Sciences 23, no. 22: 13746.
https://doi.org/10.3390/ijms232213746
APA Style
Haduch, A., Bromek, E., Pukło, R., Jastrzębska, J., Danek, P. J., & Daniel, W. A.
(2022). The Effect of the Selective N-methyl-D-aspartate (NMDA) Receptor GluN2B Subunit Antagonist CP-101,606 on Cytochrome P450 2D (CYP2D) Expression and Activity in the Rat Liver and Brain. International Journal of Molecular Sciences, 23(22), 13746.
https://doi.org/10.3390/ijms232213746